From: Optimal patient selection for maze procedure in patients undergoing mitral valve disease
(n = 43) | |
---|---|
Age | 70.7 ± 8.2 |
Sex (Female) | 18 (41.9%) |
Body height (cm) | 162.0 ± 9.9 |
Body weight (kg) | 58.1 ± 12.1 |
AF period (months) | 47.4 ± 66.5 (2〜360) |
AF period ≥ 3 years | 18 (42.9%) |
F-wave height (mV) | 0.19 ± 0.09 |
F-wave ≥ 0.1 mV | 36 (83.7%) |
LAD (mm) | 51.2 ± 8.2 |
LAD ≥ 55 mm | 13 (30.2%) |
EF (%) | 54.2 ± 10.5 |
TRPG (mmHg) | 33.0 ± 13.1 |
BNP (pg/ml) | 297.0 ± 262.9 |
Preoperative oral beta blocker | 30 (69.8%) |
Preoperative oral antiarrhythmic drugs | 11 (25.6%) |
Operation time (min) | 287.5 ± 44.7 |
Cardiopulmonary bypass time (min) | 161.0 ± 29.4 |
Aortic cross clamp time (min) | 114.4 ± 22.9 |
Isolated mitral valve surgery | 4 (9.3%) |
Combined valve surgery | 39 (90.7%) |
Simultaneous coronary artery bypass grafting | 1 (2.3%) |
Aortic valve surgery | 0 |